Has Jones Samuel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $206,566 in general payments to Jones Samuel, MD across 720 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jones Samuel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jones Samuel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jones Samuel, MD

Nephrology · Baton Rouge, LANPI 1164429437

Payments from drug & device makers

$206,566in general payments, 2019–2025

Across 720 payments — averaging $286.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$60K
Bayer$59K
Vifor Pharma, Inc.$29K
Boehringer Ingelheim$21K
Akebia Therapeutics Inc$15K
Lilly USA, LLC$8K
plus $16K from 35 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	134	$59,636
Bayer	73	$59,488
Vifor Pharma, Inc.	71	$28,599
Boehringer Ingelheim	43	$20,685
Akebia Therapeutics Inc	34	$14,808
Lilly USA, LLC	10	$7,638
Calliditas Therapeutics US Inc.	20	$2,586
Fresenius USA Marketing, Inc.	55	$2,218
Mallinckrodt Hospital Products Inc.	39	$1,506
Otsuka Pharmaceutical Development & Commercialization, Inc.	9	$1,369
Amgen(2 entities)	45	$1,352
Otsuka America Pharmaceutical, Inc.	49	$1,248
Aurinia Pharma U.S., Inc.	20	$858
Baxter Healthcare	15	$677
Medtronic	10	$529
Novartis	12	$478
Travere Therapeutics, Inc.	9	$453
Mallinckrodt Enterprises LLC	9	$361
ANI Pharmaceuticals, Inc.	10	$306
Sanofi	7	$297
GSK	8	$225
Johnson & Johnson	2	$151
Bard Peripheral Vascular, Inc.	1	$150
Daiichi Sankyo Inc.	6	$108
Esperion Therapeutics, Inc.	1	$107
Nxstage Medical, Inc.	2	$94
Abiomed	2	$76
OPKO Pharmaceuticals, LLC	5	$70
Ultragenyx Pharmaceutical Inc.	3	$68
W. L. Gore & Associates, Inc.	1	$67
Novo Nordisk	3	$65
Rockwell Medical, Inc.	1	$61
Gastroklenz, Inc. DBA Cloudcath	1	$45
Veloxis Pharmaceuticals, Inc.	2	$41
Xeris Pharmaceuticals, Inc.	2	$32
Hikma Pharmaceuticals USA	1	$23
Pharmacosmos Therapeutics Inc.	1	$21
Scpharmaceuticals Inc.	1	$20
Apellis Pharmaceuticals, Inc.	1	$19
Shire North American Group Inc	1	$17
Cormedix Inc.	1	$15

How this compares

$206,566 in reported general payments places this provider in the 95th percentile of 206 nephrology providers in Louisiana.

See all nephrology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$166,562

Medicare patients

411

Services billed

2,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Baton Rouge

Christopher LuscyBaton Rouge$1.1M
Michael RoppoloBaton Rouge$447K
Amin KamyarBaton Rouge$88K
Damodar KumbalaBaton Rouge$16K
Robert LandryBaton Rouge$13K
Raynold CoronaBaton Rouge$12K
Kiran PadigalaBaton Rouge$6K
Sreedhara AllaShreveport$1.2M
Marwan KaskasShreveport$968K
Juan Carlos VelezNew Orleans$801K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →